Skip to content

Nasdaq · CIK 0001827401

DRUG BRIGHT MINDS BIOSCIENCES INC.

Insider trading from SEC Form 4. Last filing Nov 6, 2024. Close $54.05 on Oct 9, 2026, +12% from the 52-week low and -44% from the high.

Last 90 days

Net insider value
$0
no open-market trades
Buys
0
$0 by 0 insiders
Sells
0
$0 by 0 insiders
Insiders on file
1
with a Form 4 at this company

Price and insider trades, last year

DRUGOct 9, 2026 · close 54.05

Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™

Signals

Open-market buys and sells at BRIGHT MINDS BIOSCIENCES INC., scored.

ScoreInsiderValueHoldingsPrice contextFiled
43ModerateCormorant Asset Management, LP
owner
buy
$4.0M
184,331 shares
+21%-
42ModerateCormorant Asset Management, LP
owner
buy
$3.2M
422,591 shares
+93%-

Transactions

The last 12 rows filed, every code.

DateInsiderTransactionSharesPriceValueHoldings afterFiled
Nov 4, 2024Cormorant Asset Management, LP
owner
POpen-market purchase
Common Sharesindirect: See Footnote
+184,331$21.70$4.0M1,059,331Nov 6, 2024
Oct 15, 2024Cormorant Asset Management, LP
owner
POpen-market purchase
Common Sharesindirect: See Footnote
+238,097$4.53$1.1M690,506Oct 17, 2024
Oct 15, 2024Cormorant Asset Management, LP
owner
POpen-market purchase
Common Sharesindirect: See Footnote
+63,173$5.92$374k753,679Oct 17, 2024
Oct 15, 2024Cormorant Asset Management, LP
owner
POpen-market purchase
Common Sharesindirect: See Footnote
+33,343$6.42$214k787,022Oct 17, 2024
Oct 15, 2024Cormorant Asset Management, LP
owner
POpen-market purchase
Common Sharesindirect: See Footnote
+8,900$7.31$65k795,922Oct 17, 2024
Oct 15, 2024Cormorant Asset Management, LP
owner
POpen-market purchase
Common Sharesindirect: See Footnote
+2,600$8.80$23k798,522Oct 17, 2024
Oct 15, 2024Cormorant Asset Management, LP
owner
POpen-market purchase
Common Sharesindirect: See Footnote
+2,700$9.26$25k801,222Oct 17, 2024
Oct 15, 2024Cormorant Asset Management, LP
owner
POpen-market purchase
Common Sharesindirect: See Footnote
+19,169$11.72$225k820,391Oct 17, 2024
Oct 15, 2024Cormorant Asset Management, LP
owner
POpen-market purchase
Common Sharesindirect: See Footnote
+4,609$12.35$57k825,000Oct 17, 2024
Oct 16, 2024Cormorant Asset Management, LP
owner
POpen-market purchase
Common Sharesindirect: See Footnote
+39,743$23.22$923k864,743Oct 17, 2024
Oct 16, 2024Cormorant Asset Management, LP
owner
POpen-market purchase
Common Sharesindirect: See Footnote
+7,150$24.03$172k871,893Oct 17, 2024
Oct 16, 2024Cormorant Asset Management, LP
owner
POpen-market purchase
Common Sharesindirect: See Footnote
+3,107$25.22$78k875,000Oct 17, 2024

Insiders

Everyone who has filed a Form 4 here.

Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.

DRUG insider trading: BRIGHT MINDS BIOSCIENCES INC. | InsiderTell